10x Genomics Newsroom

10x Genomics Analyst Ratings

BenzingaJul 18 08:19 ET

10x Genomics Analyst Ratings

BenzingaJul 16 07:55 ET

10x Genomics Stock Slides 14% Amid Illumina Deal, Deutsche Downgrade

Seeking AlphaJul 10 11:47 ET

Goldman Sachs Adjusts Price Target on 10x Genomics to $16 From $26, Maintains Sell Rating

MT NewswiresJul 9 10:40 ET

10x Genomics Analyst Ratings

BenzingaJul 9 10:29 ET

10x Genomics Analyst Ratings

BenzingaJun 27 07:38 ET

10x Genomics Analyst Ratings

BenzingaJun 25 08:03 ET

10x Genomics Analyst Ratings

BenzingaJun 3 14:00 ET

Analysts' Opinions Are Mixed on These Healthcare Stocks: Bausch + Lomb Corporation (BLCO), 10x Genomics (TXG) and LivaNova (LIVN)

TipRanksMay 2 22:15 ET

UBS Adjusts 10x Genomics Price Target to $30 From $52, Maintains Neutral Rating

MT NewswiresMay 1 13:11 ET

10x Genomics Analyst Ratings

BenzingaMay 1 09:02 ET

Analysts Offer Insights on Healthcare Companies: 10x Genomics (TXG), Axonics Modulation Technologies (AXNX) and Eli Lilly & Co (LLY)

TipRanksMay 1 06:50 ET

Analysts' Opinions Are Mixed on These Healthcare Stocks: 10x Genomics (TXG), Zoetis (ZTS) and Blueprint Medicines (BPMC)

TipRanksMay 1 03:45 ET

10x Genomics Analyst Ratings

BenzingaApr 29 10:47 ET

10x Genomics Analyst Ratings

BenzingaApr 18 08:14 ET

10x Genomics Analyst Ratings

BenzingaApr 10 15:40 ET

Analysts Offer Insights on Healthcare Companies: 10x Genomics (TXG) and LivaNova (LIVN)

TipRanksApr 10 02:55 ET

UBS Adjusts 10x Genomics Price Target to $52 From $44, Maintains Neutral Rating

MT NewswiresFeb 21 11:52 ET

Analysts' Opinions Are Mixed on These Healthcare Stocks: Gilead Sciences (GILD), Travere Therapeutics (TVTX) and 10x Genomics (TXG)

TipRanksFeb 16 17:40 ET

10x Genomics Analyst Ratings

BenzingaFeb 16 09:47 ET